{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-050269","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.415649+00:00","generated_at":"2026-05-29T03:14:13.469536+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspira Women's Health CEO Sandford steps down; Dr. Milligan interim CEO","bullets":["CEO Nicole Sandford departs immediately for family health matter; remains as consultant for transition.","President Dr. Sandra Milligan named interim CEO; nationwide search for permanent successor underway.","Separation: $375,000 biweekly over 9 months plus $135,000 bonus upon fundraising or by Sept 30, 2025.","Board cites Sandford's role in launching OvaWatch and securing $10M ARPA-H award for endometriosis test."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-050269","json":"https://secwatch.observer/filing/0001493152-24-050269.json","markdown":"https://secwatch.observer/filing/0001493152-24-050269.md","text":"https://secwatch.observer/filing/0001493152-24-050269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000149315224050269/0001493152-24-050269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000149315224050269/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:14:13.469536+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}